Yale Cancer Center Creates Laboratory For Earlier Detection Of Breast Cancer

October 16, 1997

Yale Cancer Center Creates Laboratory For Earlier Detection Of Breast Cancer

For Immeditate Release: 15 October 1997

Contact: Ilene Shub Lefland
Yale Cancer Center

Yale Cancer Center Creates Laboratory For Earlier Detection Of Breast Cancer

(NEW HAVEN) -- A specialized research laboratory dedicated to earlier diagnosis of breast cancer has been established at the Yale Cancer Center. Marcia Israel, a Los Angeles philanthropist with a special interest in the disease, provided the seed money for creation of this laboratory.

In designating her gift for "The Marcia Israel Laboratory for Earlier Diagnosis of Breast Cancer," Israel cited the "excellent research" being undertaken at the Yale Cancer Center under the direction of Vincent T. DeVita, Jr., M.D., and stated that "seeing a mass on a mammogram is not early enough."

Experience already gained at the Yale Cancer Center with regard to precancerous legions concerning ovarian, pancreatic and colorectal cancer places this new laboratory in a perfect position to pursue the earlier diagnosis of breast cancer. Envisioned are new tests capable of detecting very small clusters of cells before they become visible on a mammogram.

New technologies in the field of cancer research now make it possible to determine mutations in single cells as well as in genetic material extracted from a very small number of cells. The biological materials obtained through such methods as fine needle aspiration can then be analyzed with exquisite sensitivity and specificity for the genetic alterations that are the hallmark of cancerous cells. New technologies also make it possible to look for mutated cancer molecules in the blood of patients.

"Researchers at the Yale Cancer Center have hopes not only of improving the detection of small cancers, but also of being able to identify women whose breast tissue is about to become cancerous," said Jose Costa, M.D., the Cancer Center deputy director under whose supervision the new laboratory falls. "These are the patients on whom we will ultimately want to test new cancer-preventing therapies."

The Marcia Israel Laboratory for Earlier Diagnosis of Breast Cancer will begin preliminary research by October. Scientists have already begun to adapt the latest technological advances to the study of patient samples, and in collaboration with investigators and physicians from the Yale Comprehensive Breast Center, the design of clinical trials using the new techniques is underway. As director of the Yale Cancer Center, Vincent T. DeVita, Jr., M.D. will coordinate the laboratory's activities with ongoing clinical studies at the Cancer Center.

Marcia Israel was founder and CEO of "Judy's" and "G.H.Q. For Men," 104 specialty fashion stores that were sold in 1989. She has received many honors and business awards including the "Woman of the Year Award" from the Los Angeles Times, the prestigious "Entrepreneur of the Year Award" presented by the School of Business of the University of Southern California, and the "National Order of Merit" as "Officier," which is equivalent to the Legion of Honor.

Israel was appointed by President Reagan to chair the important committee dealing with "Small and Minority Business Ownership," which she served for six years. In 1982, the Secretary of the Navy appointed Israel to an 11-person board which governed the billion dollar business of the Navy and Marine exchanges. She served for three two-year appointments and received a Medal for Distinguished Service.

She is currently adjunct professor at the Marshall School of Business at USC, teaching the Undergrad Entrepreneur Program, and is Life Trustee on the Board of Directors of Cedars-Sinai Medical Center. The Yale Cancer Center welcomes Marcia Israel as a member of its Director1s Advisory Board.

The Yale Cancer Center is one of 27 Comprehensive Cancer Centers in the country designated by the National Cancer Institute and the only one in Southern New England. Bringing together the resources of Yale-New Haven Hospital and the Yale University School of Medicine, its mission encompasses patient care, research, cancer prevention and control, community outreach and education. The Cancer Information Service, a Yale Cancer Center program funded by the National Cancer Institute, provides up-to-date information on cancer prevention, detection and treatment. Trained cancer information specialists are available to answer questions Monday through Friday from 9:00 a.m. to 4:30 p.m. at 1-800-4-CANCER (1-800-422-6237).


Yale Cancer Center

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.